sodium ibandronate monohydrate

Poland

Drugs containing this active substance

  • OSAGRAND

    The medicine is used to treat postmenopausal osteoporosis, to reduce the risk of bone fractures (especially vertebrae) and to inhibit bone loss.

    Form: solution for injection

    Active substance Dosage
    sodium ibandronate monohydrate 3.375 mg

    ATC: M05BA06

    Manufacturer: S.C. Zentiva S.A., Zentiva, spol. s r.o.